COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
In COVID-19, tocilizumab reduces all-cause mortality at 28 d.
In COVID-19, tocilizumab reduces all-cause mortality at 28 d. Ann Intern Med. 2021 06; 174(6):JC63.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Humans
Interleukin-6
authors with profiles
Bram Rochwerg
Shannon M Fernando